Cogent Biosciences, Inc.

NASDAQ (USD): Cogent Biosciences, Inc. (COGT)

Last Price

10.79

Today's Change

+0.14 (1.31%)

Day's Change

10.63 - 10.97

Trading Volume

114,468

Overview

Market Cap

1 Billion

Shares Outstanding

109 Million

Avg Volume

866,560

Avg Price (50 Days)

9.80

Avg Price (200 Days)

7.61

PE Ratio

-4.33

EPS

-2.49

Earnings Announcement

31-Oct-2024

Previous Close

10.65

Open

10.95

Day's Range

10.635 - 10.97

Year Range

3.67 - 12.14

Trading Volume

114,744

Price Change Highlight

1 Day Change

1.12%

5 Day Change

-1.73%

1 Month Change

5.80%

3 Month Change

21.15%

6 Month Change

68.54%

Ytd Change

72.60%

1 Year Change

8.02%

3 Year Change

25.09%

5 Year Change

54.74%

10 Year Change

3.56%

Max Change

3.56%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes CGT9486, a selective tyrosine kinase inhibitor designed to inhibit the KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. It has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment